Antiaging Quantum Living Inc. (AAQL) EBITDA (2017 - 2025)

Antiaging Quantum Living (AAQL) has 9 years of EBITDA data on file, last reported at -$249021.0 in Q4 2025.

• Quarterly EBITDA fell 139.78% year-over-year to -$249021.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$639165.0 (up 19.18% YoY) and the FY2025 annual result came in at -$716847.0, down 74.69% from the prior year.
• EBITDA eased to -$249021.0 in Q4 2025 per AAQL's latest filing, from -$64371.0 in the prior quarter.
• The five-year high for EBITDA was -$1520.0 in Q3 2022, with the low at -$258428.0 in Q1 2024.
• Average EBITDA over 5 years is -$83562.5, with a median of -$27052.5 recorded in 2023.
• Year-over-year, EBITDA surged 80.08% in 2022 and slumped 3472.9% in 2024.
• Antiaging Quantum Living's EBITDA stood at -$19310.0 in 2021, then soared by 64.93% to -$6772.0 in 2022, then tumbled by 1344.61% to -$97829.0 in 2023, then decreased by 6.16% to -$103853.0 in 2024, then plunged by 139.78% to -$249021.0 in 2025.
• Business Quant data shows AAQL's EBITDA at -$249021.0 in Q4 2025, -$64371.0 in Q3 2025, and -$141309.0 in Q2 2025.